NG Biotech - Product Pipeline Analysis, 2018 Update

Published by Global Data on 27th December 2018 | Ref: 1127961 | This Report Is In Stock

$750 | Single User
$1500 | Site License
$2250 | Enterprise License
$750 | Single User
$1500 | Site License
$2250 | Enterprise License



NG Biotech is a biotech company that develops and manufactures novel in vitro diagnostic tools for therapy monitoring. The company’s products include whole blood pregnancy tests, M-health malaria tests, NG Test readers, antibiotic resistance tests, and OTC tests. It also develops a proprietary patented immunoassay platform for the development of quantitative and multiplex point of care diagnostics. NG Biotech’s immunoassay platform can be used to detect or monitor antibody, antigen, pathogen, parasite, hormone, drug, and others. The company provides product development, sample collection, assay calibration, optimization and validation, and integration services. Its products find applications in medical diagnostics, companion diagnostics, clinical trials, animal health diagnostics, OTC diagnostics, bio defense diagnostics, food and beverage testing, and agricultural and environmental testing. NG Biotech is headquartered in Rennes, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company NG Biotech

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

NG Biotech Company Overview 5

NG Biotech Company Snapshot 5

NG Biotech Pipeline Products and Ongoing Clinical Trials Overview 5

NG Biotech – Pipeline Analysis Overview 8

NG Biotech - Key Facts 8

NG Biotech - Major Products and Services 9

NG Biotech Pipeline Products by Development Stage 10

NG Biotech Pipeline Products Overview 12

BB-Blood Precision hCG Test - OTC 12

BB-Blood Precision hCG Test - OTC Product Overview 12

hCG Monitor 13

hCG Monitor Product Overview 13

NG-Quant CRP Test 14

NG-Quant CRP Test Product Overview 14

NG-Quant hCG 15

NG-Quant hCG Product Overview 15

NG-Quant Pf/Malaria Test 16

NG-Quant Pf/Malaria Test Product Overview 16

NG-Quant PSA Test 17

NG-Quant PSA Test Product Overview 17

NG-semiQ FOB 18

NG-semiQ FOB Product Overview 18

NG-Telediag pf/Pan Test 19

NG-Telediag pf/Pan Test Product Overview 19

NG-Test CARBA 5 20

NG-Test CARBA 5 Product Overview 20

NG-Test CTXM-15 21

NG-Test CTXM-15 Product Overview 21

NG-Test hCG Pregnancy Termination 22

NG-Test hCG Pregnancy Termination Product Overview 22

NG-Test MCR-1 23

NG-Test MCR-1 Product Overview 23

NG-Test NDM-1 24

NG-Test NDM-1 Product Overview 24

NG-Test OXA-48 25

NG-Test OXA-48 Product Overview 25

NG-Test Zika 26

NG-Test Zika Product Overview 26

NG Biotech - Key Competitors 27

NG Biotech - Key Employees 28

NG Biotech - Locations And Subsidiaries 29

Head Office 29

Recent Developments 30

NG Biotech, Recent Developments 30

Nov 08, 2016: NG Biotech To Unveil Next Generation Integrated hCG Rapid Diagnostic Blood Test, Developed In Conjunction With Atomo Diagnostics 30

Appendix 32

Methodology 32

About GlobalData 35

Contact Us 35

Disclaimer 35

Additional Details


Global Data

Publisher Information


1127961 | GDME2531791PD

Number of Pages


Report Format


This report is published by Global Data

Download Free Report Summary PDF

NG Biotech - Product Pipeline Analysis, 2018 Update [Updated: 27-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types


Buy now using our secure payment system.